Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Demand From Governments For Diagnosing Covid-19 Positive Patients
3.2.2. Rise In Demand For Non-Invasive Diagnosis
3.2.3. Growth In The Number Of Diseases
3.2.4. Funding For Research And Development
3.2.5. Technological Advancements In The Market
3.3. Key Restraints
3.3.1. High Capital Requirement
3.3.2. Lack Of High Complexity Testing Centers

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework

5. Market By Technology
5.1. Polymerase Chain Reaction
5.1.1. Real Time Pcr
5.1.2. Digital Pcr
5.2. Isothermal Nucleic Acid Amplification Technology
5.3. Other

6. Market By Product
6.1. Assays
6.2. Instruments
6.3. Software

7. Market By Application
7.1. Infectious Disease
7.1.1. Respiratory
7.1.2. Hospital Acquired Infections
7.1.3. Sexually Transmitted Infections
7.1.4. Gastro Intestinal Infections
7.2. Oncology
7.3. Prenatal
7.4. Others

8. Market By End-User
8.1. Hospitals
8.2. Clinics
8.3. Diagnostics Centres
8.4. Others

9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada

10. Company Profiles
10.1. Abbott Laboratories
10.2. Abacus Diagnostica
10.3. Biom?rieux Sa
10.4. Biocartis Nv
10.5. Danaher Corporation
10.6. Diasorin Spa
10.7. Bio-Rad
10.8. F Hoffmann-La Roche Ag
10.9. Luminex Corporation
10.10. Hologic Inc
10.11. Mesa Biotech
10.12. Spartan Biosciences Inc
10.13. Quantumdx Group Ltd
10.14. Quidel Corporation
10.15. Qiagen Nv



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Value Proposition - Laboratory, Immunoassay, And Molecular Poc Diagnostic
Figure 4: Opportunity Matrix
Figure 5: Vendor Landscape
Figure 6: North America Molecular Point Of Care Diagnostics Market, Growth Potential, By Technology, In 2018
Figure 7: North America Molecular Point Of Care Diagnostics Market, By Polymerase Chain Reaction, 2019-2028 (In $ Million)
Figure 8: North America Molecular Point Of Care Diagnostics Market, Growth Potential, By Pcr Technology, In 2018
Figure 9: North America Molecular Point Of Care Diagnostics Market, By Real Time Pcr, 2019-2028 (In $ Million)
Figure 10: North America Molecular Point Of Care Diagnostics Market, By Digital Pcr, 2019-2028 (In $ Million)
Figure 11: North America Molecular Point Of Care Diagnostics Market, By Isothermal Nucleic Acid Amplification Technology, 2019-2028 (In $ Million)
Figure 12: North America Molecular Point Of Care Diagnostics Market, By Other, 2019-2028 (In $ Million)
Figure 13: North America Molecular Point Of Care Diagnostics Market, Growth Potential, By Product, In 2018
Figure 14: North America Molecular Point Of Care Diagnostics Market, By Assays, 2019-2028 (In $ Million)
Figure 15: North America Molecular Point Of Care Diagnostics Market, By Instruments, 2019-2028 (In $ Million)
Figure 16: North America Molecular Point Of Care Diagnostics Market, By Software, 2019-2028 (In $ Million)
Figure 17: North America Molecular Point Of Care Diagnostics Market, Growth Potential, By Application, In 2018
Figure 18: North America Molecular Point Of Care Diagnostics Market, By Infectious Disease, 2019-2028 (In $ Million)
Figure 19: North America Molecular Point Of Care Diagnostics Market, Growth Potential, By Infectious Disease, In 2018
Figure 20: North America Molecular Point Of Care Diagnostics Market, By Respiratory, 2019-2028 (In $ Million)
Figure 21: North America Molecular Point Of Care Diagnostics Market, By Hospital Acquired Infections, 2019-2028 (In $ Million)
Figure 22: North America Molecular Point Of Care Diagnostics Market, By Sexually Transmitted Infections, 2019-2028 (In $ Million)
Figure 23: North America Molecular Point Of Care Diagnostics Market, By Gastro Intestinal Infections, 2019-2028 (In $ Million)
Figure 24: North America Molecular Point Of Care Diagnostics Market, By Oncology, 2019-2028 (In $ Million)
Figure 25: North America Molecular Point Of Care Diagnostics Market, By Prenatal, 2019-2028 (In $ Million)
Figure 26: North America Molecular Point Of Care Diagnostics Market, By Others, 2019-2028 (In $ Million)
Figure 27: North America Molecular Point Of Care Diagnostics Market, Growth Potential, By End-User, In 2018
Figure 28: North America Molecular Point Of Care Diagnostics Market, By Hospitals, 2019-2028 (In $ Million)
Figure 29: North America Molecular Point Of Care Diagnostics Market, By Clinics, 2019-2028 (In $ Million)
Figure 30: North America Molecular Point Of Care Diagnostics Market, By Diagnostic Centres, 2019-2028 (In $ Million)
Figure 31: North America Molecular Point Of Care Diagnostics Market, By Others, 2019-2028 (In $ Million)
Figure 32: North America Molecular Point Of Care Diagnostics Market, Regional Outlook, 2019 & 2028 (In %)
Figure 33: United States Molecular Point Of Care Diagnostics Market, 2019-2028 (In $ Million)
Figure 34: Canada Molecular Point Of Care Diagnostics Market, 2019-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - MOLECULAR POINT OF CARE DIAGNOSTICS
TABLE 2: EMERGENCY USE AUTHORISATION FOR DIAGNOSTICS BY FDA
TABLE 3: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PCR TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PCR TECHNOLOGY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 10: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY INFECTIOUS DISEASE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY INFECTIOUS DISEASE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: NORTH AMERICA MOLECULAR POINT OF CARE DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)